KẾT QUẢ SỚM PHẪU THUẬT CẮT THỰC QUẢN XÂM LẤN TỐI THIỂU TRÊN NHÓM BỆNH NHÂN UNG THƯ BIỂU MÔ VẢY THỰC QUẢN HÓA XẠ TRỊ TIỀN PHẪU TẠI BỆNH VIỆN K

Abstract

Abtract: Esophageal cancer is a poor prognosis disease. Preoperative chemoradiotherapy followed by surgery has been shown to reduce recurrence rate, increase overall survival, increase chance of R0 resection rate. Methodology: A prospective descriptive study was performed on a group of middle-lower third esophageal cancer who underwent preoperative chemoradiotherapy and follow by thoraco-laparoscopic esophagectomy with lymph node dissection from September 2022 to May 2023 at Department of Abdominal Surgery I – National Cancer Hospital. Result: With the sample size is 20 patients, we recognized the intraoperative complications were pleural tear (40%)  and the main postoperative complication were pneumonia (25%), recurrent laryngeal nerve injury (10%). 45% of the patients have no residual viable primitive tumour at pathological examination and the average number of retrieved lymph node was 33,5 ± 15,2 per-patient. Conclusion: This prospective study demonstrates that thoraco-laparoscopic esophagectomy and lymph node dissection follow preoperative chemoradiotherapy is feasible and safe with with an acceptable rate of postoperative complications.